Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome

Irritable Bowel Syndrome (IBS) and Chronic Constipation

New Protocol for Production of Reduced-Gluten Wheat Bread and Pasta and Clinical Effect in Patients with Irritable Bowel Syndrome: A randomised, Double-Blind, Cross-Over Study

doi: 10.3390/nu10121873.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study

Gut.

El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T

doi: 10.1136/gutjnl-2019-319630.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Curr Med Res Opin.

Barish CF, Crozier RA, Griffin P

doi: 10.1080/03007995.

RECOMMENDED

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial

★ 2 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

doi: 10.1016/S2468-1253(20)30056-X.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Efficacy and Safety of Peppermint Oil in a Randomized Double-blind Trial of Patients With Irritable Bowel Syndrome

Gastroenterology.

Weerts ZZRM, Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers JRBJ, Frijlink HW, Muris JWM, De Wit NJ, Essers BAB, Tack J, Snijkers JWT, Bours AMH, de Ruiter-van der Ploeg AS, Jonkers DMAE, Keszthelyi D

doi: 10.1053/j.gastro.2019.08.026.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

The overlap of irritable bowel syndrome and noncoeliac gluten sensitivity

Curr Opin Gastroenterol.

Rej A, Sanders DS

doi: 10.1097/MOG.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults

Gastroenterology.

Carrasco-Labra A, Lytvyn L, Falck-Ytter Y, Surawicz CM, Chey WD

doi: 10.1053/j.gastro.2019.06.014.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

Lancet Gastroenterol Hepatol.

Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ

doi: 10.1016/S2468-1253

Further Publications

A non-viable probiotic in irritable bowel syndrome - a randomized, double-blind, placebo-controlled, multi-center study

Clin Gastroenterol Hepatol

Mack I, Schwille-Kiuntke J, Mazurak N, Niesler B, Zimmermann K, Mönnikes H, Enck P

doi: 10.1016/j.cgh.2021.06.028

Related content

New Protocol for Production of Reduced-Gluten Wheat Bread and Pasta and Clinical Effect in Patients with Irritable Bowel Syndrome: A randomised, Double-Blind, Cross-Over Study

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial

Efficacy and Safety of Peppermint Oil in a Randomized Double-blind Trial of Patients With Irritable Bowel Syndrome

The overlap of irritable bowel syndrome and noncoeliac gluten sensitivity

AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

A non-viable probiotic in irritable bowel syndrome - a randomized, double-blind, placebo-controlled, multi-center study